New Key Statistics Module, Z-Score and F-Score
NAS:ABUS Key Ratios
| Market Cap $ M | 559.55 |
| Enterprise Value $ M | 416.89 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.63 |
| Price/Sales | 38.01 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 12.00 |
| EPS (TTM) $ | -0.44 |
| Beneish M-Score | -2.59 |
| 10-y EBITDA Growth Rate % | 13.10 |
| 5-y EBITDA Growth Rate % | 25.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.63 |
| EV-to-EBITDA | -5.74 |
| PEG | -- |
| Shares Outstanding M | 188.72 |
| Net Margin (%) | -572.81 |
| Operating Margin % | -616.64 |
| Pre-tax Margin (%) | -572.81 |
| Quick Ratio | 6.69 |
| Current Ratio | 6.69 |
| ROA % (ttm) | -45.28 |
| ROE % (ttm) | -60.12 |
| ROIC % (ttm) | -238.00 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.50 |
ABUS Number of Guru Trades
ABUS Volume of Guru Trades
Gurus Latest Trades with NAS:ABUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABUS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arbutus Biopharma Corp Insider Transactions
No Available Data
News about NAS:ABUS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers